New mRNA flu shot enters first human tests
NCT ID NCT05426174
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial tested a new mRNA-based flu vaccine in 233 healthy adults aged 18 and older. The study compared three different doses of the experimental vaccine to a standard high-dose flu shot. Researchers monitored safety and immune responses over time to see if the new vaccine could be a promising option for flu prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mRNA NA vaccine
What this could lead to
If successful, this could lead to a new type of flu vaccine that may offer better protection against influenza.
What could go wrong
This is an early Phase 1 trial with only 233 participants, so safety and effectiveness are not yet proven. The vaccine may not work as hoped or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AES - DRS - Optimal Research_Site 8400001
Peoria, Illinois, 61614-4885, United States
-
AES - DRS - Optimal Research_Site 8400002
Melbourne, Florida, 32934-8172, United States
-
AES - DRS - Optimal Research_Site 8400007
Huntsville, Alabama, 35802, United States
-
Central Phoenix Medical Clinic, LLC_Site: 8400010
Phoenix, Arizona, 85020, United States
-
Optimal Research San Diego, LLC_Site: 8400009
San Diego, California, 92108, United States
-
Synexus Clinical Research_Site 8400003
Cincinnati, Ohio, 45236, United States